Blood tests reveal how leukemia drug works in patients

NCT ID NCT07243483

Recruiting now Knowledge-focused Sponsor: Centre Leon Berard Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the drug venetoclax behaves in the bodies of 100 adults with acute myeloid leukemia (AML). Researchers will take extra blood samples to measure drug levels and see how they relate to treatment success. The study does not change the patient's regular care and involves only minimal extra blood draws.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

CHU de Grenoble
RECRUITING

Grenoble, 38000, France
CHU de Saint-Étienne
RECRUITING

Saint-Etienne, 42100, France
Centre Hospitalier Pierre Oudot
RECRUITING

Bourgoin, France, France
Centre Leon Berard
RECRUITING

Lyon, 69008, France
Hôpitaux Nord-Ouest - Villefranche-sur-Saône
RECRUITING

Villefranche-sur-Saône, 69400, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.